Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,005
Closed -$421K 427
2021
Q2
$421K Buy
5,005
+1,000
+25% +$80.9K 0.02% 252
2021
Q1
$332K Buy
+4,005
New +$334K 0.01% 286
2019
Q4
Sell
-5,005
Closed -$246K 344
2019
Q3
$246K Buy
+5,005
New +$226K 0.01% 280
2018
Q1
Sell
-6,200
Closed -$379K 322
2017
Q4
$379K Sell
6,200
-2,800
-31% -$178K 0.02% 202
2017
Q3
$496K Buy
+9,000
New +$457K 0.03% 158

Other funds holding CGNX

R.H. Bluestein & Co's CGNX Position: Q3 2021 in Review

R.H. Bluestein & Co sold out of Cognex (CGNX) in Q3 2021, closing a stake of 5,005 shares — an estimated $421K sold.

R.H. Bluestein & Co first reported a position in CGNX in Q3 2017 and held it in 5 quarters. The position peaked at $496K in Q3 2017. 534 funds tracked by Wall St. Rank hold CGNX as of Q3 2021.

  • R.H. Bluestein & Co reported no remaining Cognex position as of Q3 2021 after selling out during the quarter.
  • R.H. Bluestein & Co sold 5,005 Cognex shares in Q3 2021, an estimated $421K.
  • R.H. Bluestein & Co first reported a position in Cognex in Q3 2017 and held it in 5 quarters.
  • R.H. Bluestein & Co's Cognex position peaked at $496K in Q3 2017.
  • 534 funds tracked by Wall St. Rank held Cognex as of Q3 2021.

Based on R.H. Bluestein & Co's 13F filing for Q3 2021, filed 12 Nov 2021.